www.marijuanamoment.net Open in urlscan Pro
2606:4700:3036::ac43:d5b3  Public Scan

URL: https://www.marijuanamoment.net/canadian-senators-call-for-immediate-launch-of-psychedelics-research-program-to-explore-treatmen...
Submission: On November 11 via manual from US — Scanned from CA

Form analysis 3 forms found in the DOM

GET https://www.marijuanamoment.net/

<form method="get" id="searchform" action="https://www.marijuanamoment.net/">
  <input type="text" name="s" id="s" value="Search" onfocus="if (this.value == &quot;Search&quot;) { this.value = &quot;&quot;; }" onblur="if (this.value == &quot;&quot;) { this.value = &quot;Search&quot;; }">
  <input type="hidden" id="searchsubmit" value="Search">
</form>

POST

<form id="mc4wp-form-2" class="mc4wp-form mc4wp-form-869" method="post" data-id="869" data-name="Marijuana News In Your Inbox">
  <div class="mc4wp-form-fields">
    <p>
      <label>Email address: </label>
      <input type="email" name="EMAIL" placeholder="Your email address" required="">
    </p>
    <p>
      <input type="submit" value="Sign up">
    </p>
  </div><label style="display: none !important;">Leave this field empty if you're human: <input type="text" name="_mc4wp_honeypot" value="" tabindex="-1" autocomplete="off"></label><input type="hidden" name="_mc4wp_timestamp"
    value="1699719284"><input type="hidden" name="_mc4wp_form_id" value="869"><input type="hidden" name="_mc4wp_form_element_id" value="mc4wp-form-2">
  <div class="mc4wp-response"></div>
</form>

POST

<form id="mc4wp-form-3" class="mc4wp-form mc4wp-form-869" method="post" data-id="869" data-name="Marijuana News In Your Inbox">
  <div class="mc4wp-form-fields">
    <p>
      <label>Email address: </label>
      <input type="email" name="EMAIL" placeholder="Your email address" required="">
    </p>
    <p>
      <input type="submit" value="Sign up">
    </p>
  </div><label style="display: none !important;">Leave this field empty if you're human: <input type="text" name="_mc4wp_honeypot" value="" tabindex="-1" autocomplete="off"></label><input type="hidden" name="_mc4wp_timestamp"
    value="1699719284"><input type="hidden" name="_mc4wp_form_id" value="869"><input type="hidden" name="_mc4wp_form_element_id" value="mc4wp-form-3">
  <div class="mc4wp-response"></div>
</form>

Text Content

 * Politics
 * Science & Health
 * Culture
 * Business
 * Video
 * Newsletter
   * Subscribe
 * Remove Ads
 * Bill Tracking
   * About
   * Login Instructions
   * All 2023 Cannabis Bills
   * Bill Hearing Calendar
 * About Marijuana Moment
   * Support Marijuana Moment
   * Subscribe To Newsletter

Connect with us
 * 
 * 
 * 


MARIJUANA MOMENT

CANADIAN SENATORS CALL FOR ‘IMMEDIATE’ LAUNCH OF PSYCHEDELICS RESEARCH PROGRAM
TO EXPLORE TREATMENTS FOR MILITARY VETERANS


 * Politics
   
    * Members Of New Hampshire Marijuana Legalization Commission Spar On Details
      Ahead Of Looming Bill Deadline
   
    * First-Ever Congressional Hearing On Psychedelic-Assisted Mental Health
      Care For Veterans Will Be Held Tuesday
   
    * German Lawmakers Postpone Marijuana Legalization Vote Scheduled For Next
      Week, Pushing Proposed Reform Into 2024
   
    * As Ohio Voters Approved Statewide Marijuana Legalization, Three More
      Cities Decriminalized Even Larger Amounts Of Cannabis
   
    * Former FDA Official Says He’d Be ‘Shocked’ If DEA Doesn’t Reschedule
      Marijuana By 2024 Election

 * Science & Health
   
    * States That Legalize Marijuana See ‘Significantly’ Lower Rate Of Cannabis
      Use Disorder Cases At ERs Compared To Non-Legal States, Study Finds
   
    * Federal Health Agency Announces $2 Million In Funding To Develop
      Psychedelic Treatments For Substance Use Disorders
   
    * New FDA Documents Look Back On 50 Years Of Marijuana Research While
      Previewing Future Studies On Terpenes And Edibles
   
    * Letting People Legally Buy CBD Significantly Reduces Opioid Prescription
      Rates, New Study Shows
   
    * Federal Health Agency Awards $3.2 Million Grant To Study Impact Of
      Marijuana On Cancer Immunotherapy Treatment

 * Culture
   
    * SXSW Announces 2024 Lineup, Leaning Into Psychedelics While Nixing
      Cannabis Track
   
    * Jimmy Kimmel Proclaims October 20—Snoop Dogg’s Birthday And Midpoint To
      4/20—As New Marijuana Holiday Called ‘DoggFather’s Day’
   
    * NCAA Panel Formally Recommends Removing Marijuana From Banned Substances
      List For College Athletes
   
    * Illinois Concert This Weekend Will Be State’s First To Allow On-Site
      Marijuana Consumption
   
    * World Anti-Doping Agency Experts Say Marijuana Use Violates The ‘Spirit Of
      Sport’ And Makes Athletes Unfit Role Models

 * Business
   
    * Missouri Marijuana Retailer Settles Labor Dispute After Terminating
      Employees Who Tried To Form Union
   
    * Maryland Dispensaries Sold $90 Million In Legal Marijuana In October,
      Including Record Amount Of Adult-Use Cannabis
   
    * Sales Of Hemp-Derived Cannabinoids Like CBD Outpace Legal Marijuana And
      Are On Par With Craft Beer, Report Finds
   
    * Home Values Have Increased Significantly More In States That Legalized
      Marijuana Than Those That Kept Criminalization, Real Estate Study Finds
   
    * Arkansas Made $23.5 Million In Medical Marijuana Tax Revenue So Far This
      Year, With State On Track For New Sales Record

 * Video
   
    * Members Of New Hampshire Marijuana Legalization Commission Spar On Details
      Ahead Of Looming Bill Deadline
   
    * GOP Presidential Candidate Ramaswamy Says He Voted Against Ohio Marijuana
      Legalization Because Feds Could ‘Weaponize’ Criminalization In ‘Fake’
      Legal States
   
    * White House Says ‘Nothing Has Changed’ With Biden’s Marijuana Stance As
      Ohio Becomes Latest State To Legalize
   
    * Schumer Touts Ohio’s Marijuana Legalization Vote As Example Of Americans
      Rejecting ‘MAGA Extremism’
   
    * GOP Presidential Candidate Vivek Ramaswamy Says He Voted Against
      Legalizing Marijuana In Ohio

 * Newsletter
   
    * White House & Schumer talk cannabis in OH (Newsletter: November 10, 2023)
   
    * Record-high cannabis support in Gallup poll (Newsletter: November 9, 2023)
   
    * Ohio voters legalize cannabis (Newsletter: November 8, 2023)
   
    * Cannabis amendments in Congress (Newsletter: November 7, 2023)
   
    * FDA looks to future of cannabis research (Newsletter: November 6, 2023)
   
   * Subscribe
 * Remove Ads
 * Bill Tracking
   * About
   * Login Instructions
   * All 2023 Cannabis Bills
   * Bill Hearing Calendar
 * About Marijuana Moment
   * Support Marijuana Moment
   * Subscribe To Newsletter




POLITICS


CANADIAN SENATORS CALL FOR ‘IMMEDIATE’ LAUNCH OF PSYCHEDELICS RESEARCH PROGRAM
TO EXPLORE TREATMENTS FOR MILITARY VETERANS

Published

3 days ago

on

November 8, 2023

By

Kyle Jaeger

A Canadian Senate committee is calling on the federal government to launch a
“large-scale research program” to explore the therapeutic potential of
psychedelics like psilocybin and MDMA to treat mental health conditions that
commonly afflict military veterans.

At a press conference on Wednesday, the Senate Subcommittee on Veterans Affairs
unveiled a report that recommends “the immediate implementation of a robust
research program” funded by Veterans Affairs Canada (VAC) and the Department of
Defence, in partnership with federal health agencies, to carry out studies into
the efficacy of psychedelic-assisted therapy for veterans with conditions such
as post-traumatic stress disorder (PTSD).



The panel criticized VAC’s current “wait-and-see” approach to psychedelic
medicine, calling it “ill-suited” to meet the moment and arguing that the agency
“should be doing everything in its power to improve the health of veterans,
particularly those who have exhausted all the treatment options available to
them.”

A comprehensive research program would both ensure that the government is doing
its part to explore all potential therapeutic options that could be available to
the veteran community while determining whether psychedelic treatment is “proven
or qualified.”

“Research on these subjects is constantly evolving and will continue to do so.
No one can predict whether progress will be spectacular or whether there will be
setbacks. What we know today is that there is no reason to wait for results from
other countries, because the results would still need to be confirmed for our
veterans,” the report says. “It is the Government of Canada’s duty to assure
veterans that it is doing everything in its power, immediately, to respect its
solemn commitment to support, at any cost, those who chose to defend us with
honour.”



Sen. David Richards, chair of the subcommittee, said that the panel “heard
harrowing stories from veterans who have returned home from conflict zones only
to face the darkest moment of their lives.”

“The research into psychedelic-assisted therapy is too promising to ignore,” he
said. “Our veterans sacrifice so much—we must do everything we can to help
them.”



The report from the subcommittee—which falls under the Committee on National
Security and Defence—is titled “The Time is Now: Granting equitable access to
psychedelic-assisted therapies.” But contrary to the implication, members made
clear that they are not recommending that substances be made immediately
available for regulated use in the short-term. Rather, they argue the science
must guide next steps before therapeutic access is widely approved.

“The advantages and risks associated with these substances are known only when
taken in a very regulated psychotherapeutic context, usually involving two
psychotherapists for an extended period,” the report says. “Subcommittee members
believe that expanding access without being able to guarantee a safe environment
is too risky, given our current limited knowledge.”



“Even the most cautious recognize the tremendous potential of psychedelics in
conjunction with a structured psychotherapeutic approach. However, scientific
evidence confirming these results is not strong enough to overcome the real and
perceived risks associated with these substances. There is also insufficient
evidence of the beneficial effects of these substances among veterans, who tend
to respond differently to treatments than the general public, and yet all
studies to date have only involved the general public.”



The report comes as a coalition of Canadian medical professionals is asking the
Federal Court of Canada to overturn an earlier ruling that denied them access to
use psilocybin that they want to personally use for training purposes to better
serve patients seeking psychedelic-assisted therapy. Meanwhile, individuals
suffering from terminal conditions like cancer are able to apply to participate
in a “special access program” through Health Canada to utilize psilocybin.

The Senate subcommittee recognized that its recommendation to establish a
veterans-focused research program “will surely come as a disappointment to those
witnesses who would have preferred granting much wider access to psychedelic
substances.”



“Subcommittee members wish to help expand this access, but in a way that takes
into account both the limited scientific knowledge and the current capacity of
health care professionals to offer therapeutic support safely,” it said.
“Although the encouraging findings of the preliminary studies have made some
people eager to proceed right away, if these results are confirmed, it would
still take several years before this type of psychotherapy could be provided on
a larger scale.”

Still, the Senate panel is pushing government officials to accelerate efforts to
investigate the healing potential of psychedelics.

“The Subcommittee does not want to downplay VAC’s efforts to support veterans,
but Subcommittee members would like to emphasize that the Department must
recognize the urgency of addressing the outstanding questions about the
therapeutic value of psychedelics, and that it must take the lead on
implementing this recommendation quickly,” the report says.

“We owe it to our veterans to explore every possibility. They should not be left
to explore these options on their own. The entire hierarchy of the Canadian
Armed Forces, of the Royal Canadian Mounted Police, every employee at Veterans
Affairs Canada and the entire Government of Canada, plus whatever researchers
and health care professionals that the government can mobilize, should tackle
this issue without hesitation. These veterans are suffering because they rose to
the highest calling of our nation. In return, Canadian decision-makers should do
everything in their power, explore every avenue, leave no stone unturned, in
case even one is hiding a wisp of a solution that could help them improve their
daily lives. Let’s tackle this problem with all available resources, motivated
by their despair. What could be more important than that?”



Across the border in the U.S., lawmakers on both sides of the aisle have also
expressed interest in exploring the therapeutic potential of psychedelics for
veterans.

For example, pair of measures to encourage studies into the therapeutic
potential of psychedelics like psilocybin and MDMA were approved by the House in
September as part of a Department of Defense (DOD) spending bill.

Rep. Morgan Luttrell (R-TX), co-founding member of the Congressional
Psychedelics Advancing Therapies (PATH) Caucus, has publicly shared how
treatment with ibogaine and 5-MeO-DMT “changed my life” and was “one of the
greatest things that ever happened to me.” Earlier this year, he and several
other GOP lawmakers spoke in favor of a bill to create a $75 million federal
grant program to support research into the therapeutic potential of
psychedelics for certain health conditions among active duty military service
members.

A congressional subcommittee’s hearing on the use of psychedelic-assisted
treatments for mental health disorders was supposed to be held last month, but
it was postponed indefinitely amid a leadership scramble and it’s not yet clear
when the rescheduled event will be.

Last month, the U.S. Department of Veterans Affairs (VA) launched a new podcast
about the future of veteran health care, with its first episode focused on the
healing potential of psychedelics.

> Medical Marijuana Prescriptions Rise Sharply In Israel Amid War With Hamas,
> Government Says As Patients Seek Relief From PTSD And Pain



Photo courtesy of Dick Culbert.

Marijuana Moment is made possible with support from readers. If you rely on our
cannabis advocacy journalism to stay informed, please consider a monthly Patreon
pledge.
Related Topics:featured

Up Next

Top GOP Ohio Lawmakers And Prohibitionist Groups Push To Overturn Voter-Approved
Marijuana Legalization Initiative Or Amend Key Provisions

Don't Miss

Florida Supreme Court Hears Arguments In Case To Decide If Marijuana
Legalization Will Appear On 2024 Ballot

Kyle Jaeger


Kyle Jaeger is Marijuana Moment's Sacramento-based managing editor. His work has
also appeared in High Times, VICE and attn.



YOU MAY LIKE

Members Of New Hampshire Marijuana Legalization Commission Spar On Details Ahead
Of Looming Bill Deadline

First-Ever Congressional Hearing On Psychedelic-Assisted Mental Health Care For
Veterans Will Be Held Tuesday

German Lawmakers Postpone Marijuana Legalization Vote Scheduled For Next Week,
Pushing Proposed Reform Into 2024

As Ohio Voters Approved Statewide Marijuana Legalization, Three More Cities
Decriminalized Even Larger Amounts Of Cannabis

States That Legalize Marijuana See ‘Significantly’ Lower Rate Of Cannabis Use
Disorder Cases At ERs Compared To Non-Legal States, Study Finds

Former FDA Official Says He’d Be ‘Shocked’ If DEA Doesn’t Reschedule Marijuana
By 2024 Election

Advertisement

MARIJUANA NEWS IN YOUR INBOX

Email address:



Leave this field empty if you're human:



SUPPORT MARIJUANA MOMENT



 * 
 * 
 * 

 * About Marijuana Moment
 * Subscribe
 * Sponsorship and Advertising
 * Privacy Policy

All the cannabis news you need, all in one place. Copyright © 2017-2023
Marijuana Moment LLC ® and Tom Angell




Marijuana Moment












MARIJUANA NEWS IN YOUR INBOX

Email address:



Leave this field empty if you're human:

×